Global Angio Suites Market Set to Reach grow at a CAGR of 9.1% through 2032 Driven by Rising Cardiovascular Disease Prevalence

Posted on 2024-10-11 by Future Market Insights in Healthcare // 0 Comments

The global angio suites market is poised for remarkable growth, with projections estimating it will reach USD 2.52 billion by the end of 2022, and maintain a robust compound annual growth rate (CAGR) of 9.1% through 2032. This growth is largely driven by the increasing global prevalence of cardiovascular diseases, which remain the leading cause of death worldwide.

According to recent reports, cardiovascular diseases now account for approximately 29% of all global deaths. In the United States alone, forecasts suggest that 40.5% of the population will be affected by cardiovascular diseases by 2030. These alarming statistics highlight the urgent need for advanced medical interventions, such as those provided by angio suites, to manage the growing burden of heart disease.

Angio suites are cutting-edge facilities equipped with state-of-the-art imaging technologies and surgical tools that enable precise, minimally invasive procedures like angiography, angioplasty, and stenting. These advanced capabilities significantly reduce patient recovery times and improve clinical outcomes, making them essential in the treatment and diagnosis of cardiovascular conditions.

Despite the market’s promising outlook, certain challenges remain. High setup and installation costs, along with limited healthcare infrastructure in developing regions, may hinder market expansion. However, the outlook remains optimistic as technological advancements and increased investment in healthcare infrastructure are expected to fuel further growth during the forecast period.

“The rising burden of cardiovascular diseases globally underscores the critical need for advanced medical equipment like angio suites,” said FMI. “We anticipate continued growth in this market as healthcare providers seek to enhance patient care through advanced diagnostic and therapeutic capabilities.”

The projected growth of the angio suites market aligns with broader trends in healthcare, including the shift toward precision medicine and minimally invasive procedures. As technological innovations continue to evolve, these trends are expected to accelerate market expansion, benefiting healthcare providers and patients worldwide.

With the growing demand for better cardiovascular care solutions, the angio suites market is expected to play a crucial role in improving patient outcomes and addressing the global cardiovascular health crisis.

Key Research Insights Drawn from the Report

In a consolidated market structure, the top three companies operating in the global angio suites landscape hold a whopping revenue share of around 70%.
Easy, fast-track FDA clearance holds vital importance in shaping the new product developments and launches.
Innovative therapy suites and angio suites are receiving wider platforms in recent years, with growing government funds and consistently increasing voluntary funds – pushing R&D activities further.

High Demand for Market Insights: Discover Comprehensive Trends in Our Full Report!

Competitive Landscape:

This section of the report presents profiles of major participants in the angio suites market, highlighting their market share, organizational structure, product portfolios, unique strategies, corporate dashboard, and marketing approaches. Notable companies featured include GE Healthcare, Koninklijke Philips N.V., Siemens AG, Shimadzu Corporation, Canon, Inc., among others. Emerging players in the angio suites market are primarily concentrating on innovative marketing tactics to enhance their market presence globally.

Segmentation

The report offers a comprehensive taxonomy of the angio suites market on the basis of product type, end user and region. On the basis of product type, the global angio suites market has been segmented into biplane angio suites and single plane angio suites.

On the basis of end user, the global angio suites market has been segmented into hospitals and cath labs. From a geographical perspective, the angio suites market has been segmented into North America, Latin America, Europe, Asia Pacific and Middle East & Africa (MEA).

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

Matched content

Editor’s pick